ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension

ClinicalTrials.gov ID: NCT07168902

Public ClinicalTrials.gov record NCT07168902. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 7:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Evaluation of the Safety, Ocular Tolerability, and Efficacy of Topical Ophthalmic BL1107 Versus Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension

Study identification

NCT ID
NCT07168902
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bausch & Lomb Incorporated
Industry
Enrollment
252 participants

Conditions and interventions

Conditions

Interventions

  • BL1107 High dose Drug
  • BL1107 Low dose Drug
  • Timolol maleate 0.5% Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 23, 2025
Primary completion
Apr 30, 2026
Completion
Apr 30, 2026
Last update posted
May 6, 2026

2025 – 2026

United States locations

U.S. sites
14
U.S. states
8
U.S. cities
14
Facility City State ZIP Site status
Global Research Management, Inc. Glendale California 91204
Eye Research Foundation Newport Beach California 92663
California Eye Specialist Medical Group, LLC Pasadena California 91107
Eye Associates of Fort Myers Fort Myers Florida 33901
Levenson Eye Associates Jacksonville Florida 32204
Central Florida Eye Associates Lakeland Florida 33805
Lee Shettle Eye and Hearing Largo Florida 33773
Clayton Eye Clinical Research, LLC Morrow Georgia 30260
Coastal Research Associates, LLC Roswell Georgia 30076
Heart of America Eye Care Shawnee Mission Kansas 66204
Andover Eye Associates Andover Massachusetts 01810
Scott & Christie and Associates, PC Cranberry Township Pennsylvania 16066
Total Eye Care, P.A. Memphis Tennessee 38119
Houston Eye Associates Houston Texas 77025

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07168902, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 6, 2026 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07168902 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →